Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension

Respiratory Medicine

Volumn 102, Issue 10, 2008, Pages 1431-1438

  Zlupko, Michael ^a   Harhay, Michael O ^a   Gallop, Robert ^a   Shin, Jennifer ^a   Archer Chicko, Chris ^a   Patel, Rajesh ^a   Palevsky, Harold I ^a   Taichman, Darren B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Epoprostenol; Health related quality of life (HRQOL); Heart diseases; Lung diseases; Minnesota living with heart failure (MLHF); Pulmonary arterial hypertension; Pulmonary circulation; Pulmonary hypertension; Pulmonary vascular disease; Quality of life (QOL); Scleroderma; SF 36

Indexed keywords

BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; PROSTACYCLIN; SILDENAFIL; WARFARIN;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EMOTION; EVALUATION; FATIGUE; FEMALE; HEART ATRIUM PRESSURE; HEART HEMODYNAMICS; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY HYPERTENSION SPECIFIC VERSION; QUALITY OF LIFE; QUESTIONNAIRE; SCLERODERMA; SHORT FORM 36; WEAKNESS;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHEST PAIN; EPOPROSTENOL; FATIGUE; FEMALE; HEALTH STATUS; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; WARFARIN; YOUNG ADULT;

EID: 50549089845     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.04.016     Document Type: Article

References (28)

1. Gaine S.P., and Rubin L.J. Primary pulmonary hypertension. Lancet 352 9129 (1998) 719-725
2. Rich S., Dantzker D.R., Ayres S.M., Bergofsky E.H., Brundage B.H., Detre K.M., et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107 2 (1987) 216-223
3. D'Alonzo G.E., Barst R.J., Ayres S.M., Bergofsky E.H., Brundage B.H., Detre K.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115 5 (1991) 343-349
4. Badesch D.B., Abman S.H., Ahearn G.S., Barst R.J., McCrory D.C., Simonneau G., et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 Suppl.1 (2004) 35S-62S
5. Badesch D.B., Abman S.H., Simonneau G., Rubin L.J., and McLaughlin V.V. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 131 6 (2007) 1917-1928
6. McLaughlin V.V., Presberg K.W., Doyle R.L., Abman S.H., McCrory D.C., Fortin T., et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 Suppl. 1 (2004) 78S-92S
7. Taichman D.B., and Mandel J. Epidemiology of pulmonary arterial hypertension. Clin Chest Med 28 1 (2007) 1-22
8. Lopez-Campos J.L., Failde I., Masa J.F., Benitez-Maya J.M., Barrot E., Ayerbe R., et al. Factors related to quality of life in patients receiving home mechanical ventilation. Respir Med 102 4 (2008) 605-612
9. Shafazand S., Goldstein M.K., Doyle R.L., Hlatky M.A., and Gould M.K. Health-related quality of life in patients with pulmonary arterial hypertension. Chest 126 5 (2004) 1452-1459
10. Taichman D.B., Shin J., Hud L., Archer-Chicko C., Kaplan S., Sager J.S., et al. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res 6 (2005) 92
11. Chua R., Keogh A.M., Byth K., and O'Loughlin A. Comparison and validation of three measures of quality of life in patients with pulmonary hypertension. Intern Med J 36 11 (2006) 705-710
12. White J., Hopkins R.O., Glissmeyer E.W., Kitterman N., and Elliott C.G. Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res 7 (2006) 55
13. McKenna S.P., Doughty N., Meads D.M., Doward L.C., and Pepke-Zaba J. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res 15 1 (2006) 103-115
14. Hoeper M.M., Oudiz R.J., Peacock A., Tapson V.F., Haworth S.G., Frost A.E., et al. End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol 43 12 Suppl. S (2004) 48S-55S
15. Rector T., Kubo S.H., and Cohn J.N. Patient self-assessment of their congestive heart failure part 2: content, reliability, and validity of a new measure the Minnesota Living with Heart Failure Questionnaire. Heart Fail 3 (1987) 198-209
16. Cenedese E., Speich R., Dorschner L., Ulrich S., Maggiorini M., Jenni R., et al. Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J 28 4 (2006) 808-815
17. Rubin L.J., and Galie N. Pulmonary arterial hypertension: a look to the future. J Am Coll Cardiol 43 12 Suppl. S (2004) 89S-90S
18. Simonneau G., Galie N., Rubin J., Langleben D., Seeger W., Domenighetti G., et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43 12 Suppl. S (2004) 5S-12S
19. McGoon M., et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 Suppl. 1 (2004) 14S-34S
20. Barst R.J., McGoon M., Torbicki A., Sitbon O., Krowka M.J., Olschewski H., et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43 12 Suppl. S (2004) 40S-47S
21. Ware J., Kosinski M., and Dewey J.E. How to score version 2 of the SF-36 health survey (2000), QualityMetric Incorporated, Lincoln, RI p. 229
22. Rector T.S. Minnesota living with heart failure questionnaire: instructions for data collection and scoring. Available at: (2004). http://mlhfq.org [accessed 10.13.2004]
23. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1 (1990) 43-46
24. Shapiro S.S., and Wilk M.B. An anlysis of variance test for normality. Biometrika 52 (1965) 591-611
25. Gomberg-Maitland M., Thenappan T., Rizvi K., Chandra S., Meads D.M., and McKenna S.P. United States validation of the Cambridge pulmonary hypertension outcome review. J Heart Lung Transplant 27 (2008) 124-130
26. Kawut S.M., Horn E.M., Berekashvili K.K., Garofano R.P., Goldsmith R.L., Wildlitz A.C., et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 95 2 (2005) 199-203
27. Idler E.L., and Benyamini Y. Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 38 1 (1997) 21-37
28. Benyamini Y., and Idler E.L. Community studies reporting association between self-rated health and mortality; additional studies, 1995-1998. Res Aging 21 (1999) 392-401